• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Action of C-type natriuretic peptide in isolated canine arteries and veins.

作者信息

Wei C M, Aarhus L L, Miller V M, Burnett J C

机构信息

Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, Minnesota 55905.

出版信息

Am J Physiol. 1993 Jan;264(1 Pt 2):H71-3. doi: 10.1152/ajpheart.1993.264.1.H71.

DOI:10.1152/ajpheart.1993.264.1.H71
PMID:8430863
Abstract

C-type natriuretic peptide (CNP) is a hormone that shares structural homology to atrial natriuretic peptide (ANP); however, distinct receptors have been found for each in cultured aortic endothelial and smooth muscle cells. CNP in vivo reduces arterial pressure, atrial pressures, and cardiac output. These actions are consistent with a decrease in cardiac preload. Therefore, the current studies were designed to test the hypothesis that CNP is a vasodilator distinct from ANP. Rings of canine renal and saphenous arteries and renal, saphenous, and femoral veins with and without endothelium were suspended to measure isometric force in an organ chamber. CNP caused significant concentration-dependent relaxations in veins with and without endothelium contracted with phenylephrine (10(-6) log M). In marked contrast, ANP caused no significant relaxation in veins either with or without endothelium. In arterial rings, responses to the peptides were heterogeneous. ANP caused relaxation in renal but not saphenous arteries. CNP induced modest and comparable relaxation in rings of saphenous but not renal arteries with and without endothelium. These results demonstrate that: 1) CNP and not ANP is a relaxing factor of isolated peripheral canine veins, and 2) the responses of arteries to ANP and CNP are heterogeneous. These findings support a distinct biological role for CNP in the regulation of cardiovascular tone.

摘要

相似文献

1
Action of C-type natriuretic peptide in isolated canine arteries and veins.
Am J Physiol. 1993 Jan;264(1 Pt 2):H71-3. doi: 10.1152/ajpheart.1993.264.1.H71.
2
Mechanism of relaxations to C-type natriuretic peptide in veins.静脉对C型利钠肽舒张反应的机制。
Am J Physiol. 1996 Nov;271(5 Pt 2):H1907-11. doi: 10.1152/ajpheart.1996.271.5.H1907.
3
Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.自发性高血压大鼠的心房利钠肽和C型利钠肽及其体外血管舒张作用。
Hypertension. 1994 Jun;23(6 Pt 2):903-7. doi: 10.1161/01.hyp.23.6.903.
4
Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.血管钠尿肽:一种独特的合成利钠和血管舒张肽。
J Clin Invest. 1993 Oct;92(4):2048-52. doi: 10.1172/JCI116800.
5
Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.血管钠尿肽受体相关颗粒型鸟苷酸环化酶受一氧化氮-环鸟苷酸信号通路调节。
Br J Pharmacol. 2003 Aug;139(7):1289-96. doi: 10.1038/sj.bjp.0705365.
6
Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.内皮衍生的一氧化氮通过使血管平滑肌中大电导钙激活钾通道脱敏来抑制利钠肽引起的猪冠状动脉舒张。
J Pharmacol Exp Ther. 2010 Jul;334(1):223-31. doi: 10.1124/jpet.110.166652. Epub 2010 Mar 23.
7
Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.心房利钠肽和脑利钠肽刺激牛主动脉内皮细胞产生和分泌C型利钠肽。
J Clin Invest. 1995 Mar;95(3):1151-7. doi: 10.1172/JCI117763.
8
Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia.心房利钠肽在内膜增生过程中可维持内皮功能。
J Vasc Res. 2005 Mar-Apr;42(2):101-10. doi: 10.1159/000083429. Epub 2005 Jan 19.
9
[Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].[血管钠肽、C型利钠肽和心房利钠肽血管舒张作用的比较]
Sheng Li Xue Bao. 1999 Oct;51(5):515-20.
10
Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries.猪冠状动脉中性别与对C型利钠肽的舒张反应
J Cardiovasc Pharmacol. 1998 Jul;32(1):5-11. doi: 10.1097/00005344-199807000-00002.

引用本文的文献

1
Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics.鸟苷酸环化酶/利钠肽受体-A:鉴定、分子特征及生理基因组学
Front Mol Neurosci. 2023 Jan 4;15:1076799. doi: 10.3389/fnmol.2022.1076799. eCollection 2022.
2
Natriuretic peptide pathways in heart failure: further therapeutic possibilities.心力衰竭中的利钠肽途径:更多的治疗可能性。
Cardiovasc Res. 2023 Feb 3;118(18):3416-3433. doi: 10.1093/cvr/cvac125.
3
Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.
尿和血浆 C 型利钠肽在急性失代偿性心力衰竭中的预后价值。
JACC Heart Fail. 2021 Sep;9(9):613-623. doi: 10.1016/j.jchf.2021.04.013. Epub 2021 Jul 7.
4
From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery.从动物毒素到药物:药物发现中的成就、挑战与展望
Front Pharmacol. 2020 Jul 24;11:1132. doi: 10.3389/fphar.2020.01132. eCollection 2020.
5
Natriuretic peptide system expression in murine and human submandibular salivary glands: a study of the spatial localisation of ANB, BNP, CNP and their receptors.利尿钠肽系统在鼠和人颌下唾液腺中的表达:对 ANB、BNP、CNP 及其受体的空间定位的研究。
J Mol Histol. 2020 Feb;51(1):3-13. doi: 10.1007/s10735-019-09849-5. Epub 2019 Nov 13.
6
C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature.C 型利钠肽:心脏和血管中的多功能旁分泌调节剂。
Int J Mol Sci. 2019 May 8;20(9):2281. doi: 10.3390/ijms20092281.
7
Natriuretic peptides in cardiometabolic regulation and disease.利钠肽在心脏代谢调节和疾病中的作用。
Nat Rev Cardiol. 2014 Jul;11(7):403-12. doi: 10.1038/nrcardio.2014.64. Epub 2014 May 13.
8
Vascular relaxation induced by C-type natriuretic peptide involves the ca2+/NO-synthase/NO pathway.C型利钠肽诱导的血管舒张涉及Ca2+/一氧化氮合酶/一氧化氮途径。
PLoS One. 2014 May 1;9(5):e95446. doi: 10.1371/journal.pone.0095446. eCollection 2014.
9
Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.蛋白质工程在心血管治疗学中的应用:心脏修复的未开发潜力。
Circ Res. 2013 Sep 13;113(7):933-43. doi: 10.1161/CIRCRESAHA.113.300215.
10
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.肾素-血管紧张素阻断联合利钠肽系统增强:对抗心力衰竭的新型治疗理念。
Circ Heart Fail. 2013 May;6(3):594-605. doi: 10.1161/CIRCHEARTFAILURE.112.000289.